PP
ECYT

PDT Partners’s Endocyte, Inc. Common Stock ECYT Stock Holding History

PDT Partners’s Portfolio ECYT Stock Details ECYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-27,300
Closed -$88K – 535
2016
Q2 		$88K Sell
27,300
-1,100
-4% -$4.03K 0.01% 435
2016
Q1 		$88K Hold
28,400
– – 0.01% 544
2015
Q4 		$114K Buy
28,400
+500
+2% +$2.3K 0.02% 372
2015
Q3 		$128K Buy
+27,900
New +$146K ﹤0.01% 1202

Other funds holding ECYT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PDT Partners's ECYT Position: Q3 2016 in Review

PDT Partners sold out of Endocyte, Inc. Common Stock (ECYT) in Q3 2016, closing a stake of 27,300 shares — an estimated $88K sold.

PDT Partners first reported a position in ECYT in Q3 2015 and held it in 4 quarters. The position peaked at $128K in Q3 2015. 90 funds tracked by Wall St. Rank hold ECYT as of Q3 2016.

  • PDT Partners reported no remaining Endocyte, Inc. Common Stock position as of Q3 2016 after selling out during the quarter.
  • PDT Partners sold 27,300 Endocyte, Inc. Common Stock shares in Q3 2016, an estimated $88K.
  • PDT Partners first reported a position in Endocyte, Inc. Common Stock in Q3 2015 and held it in 4 quarters.
  • PDT Partners's Endocyte, Inc. Common Stock position peaked at $128K in Q3 2015.
  • 90 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q3 2016.

Based on PDT Partners's 13F filing for Q3 2016, filed 14 Nov 2016.